Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

Affiliations

• ¹ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ² Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ³ GeneCentric Therapeutics, Inc., Durham, NC, USA.
• ⁴ Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ⁵ Department of Urology, Loyola University, Chicago, IL, USA.
• ⁶ Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ⁷ Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ⁸ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.
• ⁹ Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.
• ¹⁰ Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.